Cadherin-17 Antibody (1H3)

This product is produced by and distributed for Abnova, a company based in Taiwan.

This gene is a member of the cadherin superfamily, genes encoding calcium-dependent, membrane-associated glycoproteins. The encoded protein is cadherin-like, consisting of an extracellular region, containing 7 cadherin domains, and a transmembrane region but lacking the conserved cytoplasmic domain. The protein is a component of the gastrointestinal tract and pancreatic ducts, acting as an intestinal proton-dependent peptide transporter in the first step in oral absorption of many medically important peptide-based drugs. The protein may also play a role in the morphological organization of liver and intestine.

This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.

We have publications tested in 1 confirmed species: Human.

We have publications tested in 1 application: IHC-P.

Showing Publications 1 - 3 of 3.

Publications using H00001015-M01	Applications	Species
Johnson A, Wright Jp, Zhao Z et al. Cadherin 17 is frequently expressed by 'sclerosing variant' pancreatic neuroendocrine tumour. Histopathology. 2014-10-12 [PMID: 25307987] (IHC-P, Human)	IHC-P	Human
Park JH, Seol JA, Choi HJ et al. Comparison of cadherin-17 expression between primary colorectal adenocarcinomas and their corresponding metastases: the possibility of a diagnostic marker for detecting the primary site of metastatic tumour. Histopathology. 2011-01-01 [PMID: 21323956]
Su MC, Yuan RH, Lin CY et al. Cadherin-17 is a useful diagnostic marker for adenocarcinomas of the digestive system. Mod Pathol;21(11):1379-86. 2008-11-01 [PMID: 18552820]

Array H00001015-M01

• Cadherin-17 Antibodies
• Cadherin-17 ELISA Kits
• Cadherin-17 Lysates
• Cadherin-17 Proteins